Global Plasma Protein Therapeutics Market Research Report 2026(Status and Outlook)
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.The plasma protein therapeutics market is driven by the increasing prevalence of rare and chronic diseases such as hemophilia, primary immunodeficiency, and autoimmune disorders, which require life-saving plasma-derived treatments. Advances in plasma fractionation techniques and the growing demand for immunoglobulins, albumin, and clotting factors are further fueling market growth. Additionally, improvements in diagnostic technologies have led to earlier detection and treatment of these conditions, expanding the patient pool for plasma protein therapies. Increasing awareness and access to these treatments in developing regions are also contributing to market expansion.A significant challenge in the plasma protein therapeutics market is the limited availability of plasma due to the complex and time-consuming process of plasma collection and fractionation. This often results in supply shortages, which can affect patient access to essential therapies. The high cost of plasma protein therapies, due to the labor-intensive production process and stringent regulatory requirements, also poses a barrier to treatment affordability. Furthermore, the market faces increasing competition from recombinant therapies, which are being developed as alternatives to plasma-derived products, potentially impacting market share.Takeda, CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, The top five manufacturers held 73.28% of the market. North America is the major region of the global market, which takes about 40% market share.
The global Plasma Protein Therapeutics market size was estimated at USD 35330.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Plasma Protein Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Plasma Protein Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Plasma Protein Therapeutics market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Protein Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Plasma Protein Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Plasma Protein Therapeutics market size was estimated at USD 35330.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Plasma Protein Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Plasma Protein Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Plasma Protein Therapeutics market.
Global Plasma Protein Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Market Segmentation (by Type)
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
Market Segmentation (by Application)
- Hemophilia
- PID
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Plasma Protein Therapeutics Market
Overview of the regional outlook of the Plasma Protein Therapeutics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Protein Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Plasma Protein Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma Protein Therapeutics
1.2 Key Market Segments
1.2.1 Plasma Protein Therapeutics Segment by Type
1.2.2 Plasma Protein Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA PROTEIN THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Protein Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Plasma Protein Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA PROTEIN THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma Protein Therapeutics Product Life Cycle
3.3 Global Plasma Protein Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma Protein Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Plasma Protein Therapeutics Market Competitive Situation and Trends
3.8.1 Plasma Protein Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA PROTEIN THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Plasma Protein Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA PROTEIN THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma Protein Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Plasma Protein Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Plasma Protein Therapeutics Market Size by Type (2020-2025)
6.4 Global Plasma Protein Therapeutics Price by Type (2020-2025)
7 PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Protein Therapeutics Market Sales by Application (2020-2025)
7.3 Global Plasma Protein Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
8 PLASMA PROTEIN THERAPEUTICS MARKET SALES BY REGION
8.1 Global Plasma Protein Therapeutics Sales by Region
8.1.1 Global Plasma Protein Therapeutics Sales by Region
8.1.2 Global Plasma Protein Therapeutics Sales Market Share by Region
8.2 Global Plasma Protein Therapeutics Market Size by Region
8.2.1 Global Plasma Protein Therapeutics Market Size by Region
8.2.2 Global Plasma Protein Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Plasma Protein Therapeutics Sales by Country
8.3.2 North America Plasma Protein Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Plasma Protein Therapeutics Sales by Country
8.4.2 Europe Plasma Protein Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Plasma Protein Therapeutics Sales by Region
8.5.2 Asia Pacific Plasma Protein Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Plasma Protein Therapeutics Sales by Country
8.6.2 South America Plasma Protein Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Plasma Protein Therapeutics Sales by Region
8.7.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PLASMA PROTEIN THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Plasma Protein Therapeutics by Region(2020-2025)
9.2 Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Plasma Protein Therapeutics Production
9.4.1 North America Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Plasma Protein Therapeutics Production
9.5.1 Europe Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Plasma Protein Therapeutics Production (2020-2025)
9.6.1 Japan Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Plasma Protein Therapeutics Production (2020-2025)
9.7.1 China Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Takeda
10.1.1 Takeda Basic Information
10.1.2 Takeda Plasma Protein Therapeutics Product Overview
10.1.3 Takeda Plasma Protein Therapeutics Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Plasma Protein Therapeutics Product Overview
10.2.3 CSL Plasma Protein Therapeutics Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 Grifols
10.3.1 Grifols Basic Information
10.3.2 Grifols Plasma Protein Therapeutics Product Overview
10.3.3 Grifols Plasma Protein Therapeutics Product Market Performance
10.3.4 Grifols Business Overview
10.3.5 Grifols SWOT Analysis
10.3.6 Grifols Recent Developments
10.4 Octapharma
10.4.1 Octapharma Basic Information
10.4.2 Octapharma Plasma Protein Therapeutics Product Overview
10.4.3 Octapharma Plasma Protein Therapeutics Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Kedrion
10.5.1 Kedrion Basic Information
10.5.2 Kedrion Plasma Protein Therapeutics Product Overview
10.5.3 Kedrion Plasma Protein Therapeutics Product Market Performance
10.5.4 Kedrion Business Overview
10.5.5 Kedrion Recent Developments
10.6 LFB Group
10.6.1 LFB Group Basic Information
10.6.2 LFB Group Plasma Protein Therapeutics Product Overview
10.6.3 LFB Group Plasma Protein Therapeutics Product Market Performance
10.6.4 LFB Group Business Overview
10.6.5 LFB Group Recent Developments
10.7 Biotest
10.7.1 Biotest Basic Information
10.7.2 Biotest Plasma Protein Therapeutics Product Overview
10.7.3 Biotest Plasma Protein Therapeutics Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 BPL
10.8.1 BPL Basic Information
10.8.2 BPL Plasma Protein Therapeutics Product Overview
10.8.3 BPL Plasma Protein Therapeutics Product Market Performance
10.8.4 BPL Business Overview
10.8.5 BPL Recent Developments
10.9 RAAS
10.9.1 RAAS Basic Information
10.9.2 RAAS Plasma Protein Therapeutics Product Overview
10.9.3 RAAS Plasma Protein Therapeutics Product Market Performance
10.9.4 RAAS Business Overview
10.9.5 RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Basic Information
10.10.2 CBPO Plasma Protein Therapeutics Product Overview
10.10.3 CBPO Plasma Protein Therapeutics Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 Hualan Bio
10.11.1 Hualan Bio Basic Information
10.11.2 Hualan Bio Plasma Protein Therapeutics Product Overview
10.11.3 Hualan Bio Plasma Protein Therapeutics Product Market Performance
10.11.4 Hualan Bio Business Overview
10.11.5 Hualan Bio Recent Developments
10.12 Tiantan Bio
10.12.1 Tiantan Bio Basic Information
10.12.2 Tiantan Bio Plasma Protein Therapeutics Product Overview
10.12.3 Tiantan Bio Plasma Protein Therapeutics Product Market Performance
10.12.4 Tiantan Bio Business Overview
10.12.5 Tiantan Bio Recent Developments
10.13 Shuanglin Bio
10.13.1 Shuanglin Bio Basic Information
10.13.2 Shuanglin Bio Plasma Protein Therapeutics Product Overview
10.13.3 Shuanglin Bio Plasma Protein Therapeutics Product Market Performance
10.13.4 Shuanglin Bio Business Overview
10.13.5 Shuanglin Bio Recent Developments
10.14 Boya Bio
10.14.1 Boya Bio Basic Information
10.14.2 Boya Bio Plasma Protein Therapeutics Product Overview
10.14.3 Boya Bio Plasma Protein Therapeutics Product Market Performance
10.14.4 Boya Bio Business Overview
10.14.5 Boya Bio Recent Developments
10.15 Yuanda Shuyang
10.15.1 Yuanda Shuyang Basic Information
10.15.2 Yuanda Shuyang Plasma Protein Therapeutics Product Overview
10.15.3 Yuanda Shuyang Plasma Protein Therapeutics Product Market Performance
10.15.4 Yuanda Shuyang Business Overview
10.15.5 Yuanda Shuyang Recent Developments
10.16 Weiguang Bio
10.16.1 Weiguang Bio Basic Information
10.16.2 Weiguang Bio Plasma Protein Therapeutics Product Overview
10.16.3 Weiguang Bio Plasma Protein Therapeutics Product Market Performance
10.16.4 Weiguang Bio Business Overview
10.16.5 Weiguang Bio Recent Developments
10.17 Nanyue Bio
10.17.1 Nanyue Bio Basic Information
10.17.2 Nanyue Bio Plasma Protein Therapeutics Product Overview
10.17.3 Nanyue Bio Plasma Protein Therapeutics Product Market Performance
10.17.4 Nanyue Bio Business Overview
10.17.5 Nanyue Bio Recent Developments
10.18 KM Biologics
10.18.1 KM Biologics Basic Information
10.18.2 KM Biologics Plasma Protein Therapeutics Product Overview
10.18.3 KM Biologics Plasma Protein Therapeutics Product Market Performance
10.18.4 KM Biologics Business Overview
10.18.5 KM Biologics Recent Developments
11 PLASMA PROTEIN THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Plasma Protein Therapeutics Market Size Forecast
11.2 Global Plasma Protein Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma Protein Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Plasma Protein Therapeutics Market Size Forecast by Region
11.2.4 South America Plasma Protein Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Plasma Protein Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Plasma Protein Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Plasma Protein Therapeutics by Type (2026-2035)
12.1.2 Global Plasma Protein Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Plasma Protein Therapeutics by Type (2026-2035)
12.2 Global Plasma Protein Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Plasma Protein Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Plasma Protein Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma Protein Therapeutics
1.2 Key Market Segments
1.2.1 Plasma Protein Therapeutics Segment by Type
1.2.2 Plasma Protein Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA PROTEIN THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma Protein Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Plasma Protein Therapeutics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA PROTEIN THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Plasma Protein Therapeutics Product Life Cycle
3.3 Global Plasma Protein Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma Protein Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Plasma Protein Therapeutics Market Competitive Situation and Trends
3.8.1 Plasma Protein Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma Protein Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PLASMA PROTEIN THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Plasma Protein Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA PROTEIN THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma Protein Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Plasma Protein Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Plasma Protein Therapeutics Market Size by Type (2020-2025)
6.4 Global Plasma Protein Therapeutics Price by Type (2020-2025)
7 PLASMA PROTEIN THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Protein Therapeutics Market Sales by Application (2020-2025)
7.3 Global Plasma Protein Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
8 PLASMA PROTEIN THERAPEUTICS MARKET SALES BY REGION
8.1 Global Plasma Protein Therapeutics Sales by Region
8.1.1 Global Plasma Protein Therapeutics Sales by Region
8.1.2 Global Plasma Protein Therapeutics Sales Market Share by Region
8.2 Global Plasma Protein Therapeutics Market Size by Region
8.2.1 Global Plasma Protein Therapeutics Market Size by Region
8.2.2 Global Plasma Protein Therapeutics Market Size by Region
8.3 North America
8.3.1 North America Plasma Protein Therapeutics Sales by Country
8.3.2 North America Plasma Protein Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Plasma Protein Therapeutics Sales by Country
8.4.2 Europe Plasma Protein Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Plasma Protein Therapeutics Sales by Region
8.5.2 Asia Pacific Plasma Protein Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Plasma Protein Therapeutics Sales by Country
8.6.2 South America Plasma Protein Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Plasma Protein Therapeutics Sales by Region
8.7.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PLASMA PROTEIN THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Plasma Protein Therapeutics by Region(2020-2025)
9.2 Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Plasma Protein Therapeutics Production
9.4.1 North America Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Plasma Protein Therapeutics Production
9.5.1 Europe Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Plasma Protein Therapeutics Production (2020-2025)
9.6.1 Japan Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Plasma Protein Therapeutics Production (2020-2025)
9.7.1 China Plasma Protein Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Plasma Protein Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Takeda
10.1.1 Takeda Basic Information
10.1.2 Takeda Plasma Protein Therapeutics Product Overview
10.1.3 Takeda Plasma Protein Therapeutics Product Market Performance
10.1.4 Takeda Business Overview
10.1.5 Takeda SWOT Analysis
10.1.6 Takeda Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Plasma Protein Therapeutics Product Overview
10.2.3 CSL Plasma Protein Therapeutics Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 Grifols
10.3.1 Grifols Basic Information
10.3.2 Grifols Plasma Protein Therapeutics Product Overview
10.3.3 Grifols Plasma Protein Therapeutics Product Market Performance
10.3.4 Grifols Business Overview
10.3.5 Grifols SWOT Analysis
10.3.6 Grifols Recent Developments
10.4 Octapharma
10.4.1 Octapharma Basic Information
10.4.2 Octapharma Plasma Protein Therapeutics Product Overview
10.4.3 Octapharma Plasma Protein Therapeutics Product Market Performance
10.4.4 Octapharma Business Overview
10.4.5 Octapharma Recent Developments
10.5 Kedrion
10.5.1 Kedrion Basic Information
10.5.2 Kedrion Plasma Protein Therapeutics Product Overview
10.5.3 Kedrion Plasma Protein Therapeutics Product Market Performance
10.5.4 Kedrion Business Overview
10.5.5 Kedrion Recent Developments
10.6 LFB Group
10.6.1 LFB Group Basic Information
10.6.2 LFB Group Plasma Protein Therapeutics Product Overview
10.6.3 LFB Group Plasma Protein Therapeutics Product Market Performance
10.6.4 LFB Group Business Overview
10.6.5 LFB Group Recent Developments
10.7 Biotest
10.7.1 Biotest Basic Information
10.7.2 Biotest Plasma Protein Therapeutics Product Overview
10.7.3 Biotest Plasma Protein Therapeutics Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 BPL
10.8.1 BPL Basic Information
10.8.2 BPL Plasma Protein Therapeutics Product Overview
10.8.3 BPL Plasma Protein Therapeutics Product Market Performance
10.8.4 BPL Business Overview
10.8.5 BPL Recent Developments
10.9 RAAS
10.9.1 RAAS Basic Information
10.9.2 RAAS Plasma Protein Therapeutics Product Overview
10.9.3 RAAS Plasma Protein Therapeutics Product Market Performance
10.9.4 RAAS Business Overview
10.9.5 RAAS Recent Developments
10.10 CBPO
10.10.1 CBPO Basic Information
10.10.2 CBPO Plasma Protein Therapeutics Product Overview
10.10.3 CBPO Plasma Protein Therapeutics Product Market Performance
10.10.4 CBPO Business Overview
10.10.5 CBPO Recent Developments
10.11 Hualan Bio
10.11.1 Hualan Bio Basic Information
10.11.2 Hualan Bio Plasma Protein Therapeutics Product Overview
10.11.3 Hualan Bio Plasma Protein Therapeutics Product Market Performance
10.11.4 Hualan Bio Business Overview
10.11.5 Hualan Bio Recent Developments
10.12 Tiantan Bio
10.12.1 Tiantan Bio Basic Information
10.12.2 Tiantan Bio Plasma Protein Therapeutics Product Overview
10.12.3 Tiantan Bio Plasma Protein Therapeutics Product Market Performance
10.12.4 Tiantan Bio Business Overview
10.12.5 Tiantan Bio Recent Developments
10.13 Shuanglin Bio
10.13.1 Shuanglin Bio Basic Information
10.13.2 Shuanglin Bio Plasma Protein Therapeutics Product Overview
10.13.3 Shuanglin Bio Plasma Protein Therapeutics Product Market Performance
10.13.4 Shuanglin Bio Business Overview
10.13.5 Shuanglin Bio Recent Developments
10.14 Boya Bio
10.14.1 Boya Bio Basic Information
10.14.2 Boya Bio Plasma Protein Therapeutics Product Overview
10.14.3 Boya Bio Plasma Protein Therapeutics Product Market Performance
10.14.4 Boya Bio Business Overview
10.14.5 Boya Bio Recent Developments
10.15 Yuanda Shuyang
10.15.1 Yuanda Shuyang Basic Information
10.15.2 Yuanda Shuyang Plasma Protein Therapeutics Product Overview
10.15.3 Yuanda Shuyang Plasma Protein Therapeutics Product Market Performance
10.15.4 Yuanda Shuyang Business Overview
10.15.5 Yuanda Shuyang Recent Developments
10.16 Weiguang Bio
10.16.1 Weiguang Bio Basic Information
10.16.2 Weiguang Bio Plasma Protein Therapeutics Product Overview
10.16.3 Weiguang Bio Plasma Protein Therapeutics Product Market Performance
10.16.4 Weiguang Bio Business Overview
10.16.5 Weiguang Bio Recent Developments
10.17 Nanyue Bio
10.17.1 Nanyue Bio Basic Information
10.17.2 Nanyue Bio Plasma Protein Therapeutics Product Overview
10.17.3 Nanyue Bio Plasma Protein Therapeutics Product Market Performance
10.17.4 Nanyue Bio Business Overview
10.17.5 Nanyue Bio Recent Developments
10.18 KM Biologics
10.18.1 KM Biologics Basic Information
10.18.2 KM Biologics Plasma Protein Therapeutics Product Overview
10.18.3 KM Biologics Plasma Protein Therapeutics Product Market Performance
10.18.4 KM Biologics Business Overview
10.18.5 KM Biologics Recent Developments
11 PLASMA PROTEIN THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Plasma Protein Therapeutics Market Size Forecast
11.2 Global Plasma Protein Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Plasma Protein Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Plasma Protein Therapeutics Market Size Forecast by Region
11.2.4 South America Plasma Protein Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Plasma Protein Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Plasma Protein Therapeutics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Plasma Protein Therapeutics by Type (2026-2035)
12.1.2 Global Plasma Protein Therapeutics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Plasma Protein Therapeutics by Type (2026-2035)
12.2 Global Plasma Protein Therapeutics Market Forecast by Application (2026-2035)
12.2.1 Global Plasma Protein Therapeutics Sales (K MT) Forecast by Application
12.2.2 Global Plasma Protein Therapeutics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Plasma Protein Therapeutics Market Size by Type (M USD)
Table 4. Global Plasma Protein Therapeutics Market Size by Application
Table 5. Plasma Protein Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Plasma Protein Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Plasma Protein Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2025)
Table 11. Global Market Plasma Protein Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Protein Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Plasma Protein Therapeutics Sales by Type (K MT)
Table 27. Global Plasma Protein Therapeutics Market Size by Type (M USD)
Table 28. Global Plasma Protein Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Plasma Protein Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Plasma Protein Therapeutics Market Share by Type (2020-2025)
Table 32. Global Plasma Protein Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Plasma Protein Therapeutics Sales (K MT) by Application
Table 34. Global Plasma Protein Therapeutics Market Size by Application
Table 35. Global Plasma Protein Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Plasma Protein Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Plasma Protein Therapeutics Market Share by Application (2020-2025)
Table 39. Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Plasma Protein Therapeutics Market Size by Region (2020-2025)
Table 44. North America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Plasma Protein Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Plasma Protein Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Takeda Basic Information
Table 63. Takeda Plasma Protein Therapeutics Product Overview
Table 64. Takeda Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Takeda Business Overview
Table 66. Takeda SWOT Analysis
Table 67. Takeda Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Plasma Protein Therapeutics Product Overview
Table 70. CSL Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. Grifols Basic Information
Table 75. Grifols Plasma Protein Therapeutics Product Overview
Table 76. Grifols Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Grifols Business Overview
Table 78. Grifols SWOT Analysis
Table 79. Grifols Recent Developments
Table 80. Octapharma Basic Information
Table 81. Octapharma Plasma Protein Therapeutics Product Overview
Table 82. Octapharma Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Octapharma Business Overview
Table 84. Octapharma Recent Developments
Table 85. Kedrion Basic Information
Table 86. Kedrion Plasma Protein Therapeutics Product Overview
Table 87. Kedrion Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Kedrion Business Overview
Table 89. Kedrion Recent Developments
Table 90. LFB Group Basic Information
Table 91. LFB Group Plasma Protein Therapeutics Product Overview
Table 92. LFB Group Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. LFB Group Business Overview
Table 94. LFB Group Recent Developments
Table 95. Biotest Basic Information
Table 96. Biotest Plasma Protein Therapeutics Product Overview
Table 97. Biotest Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Biotest Business Overview
Table 99. Biotest Recent Developments
Table 100. BPL Basic Information
Table 101. BPL Plasma Protein Therapeutics Product Overview
Table 102. BPL Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BPL Business Overview
Table 104. BPL Recent Developments
Table 105. RAAS Basic Information
Table 106. RAAS Plasma Protein Therapeutics Product Overview
Table 107. RAAS Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. RAAS Business Overview
Table 109. RAAS Recent Developments
Table 110. CBPO Basic Information
Table 111. CBPO Plasma Protein Therapeutics Product Overview
Table 112. CBPO Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. CBPO Business Overview
Table 114. CBPO Recent Developments
Table 115. Hualan Bio Basic Information
Table 116. Hualan Bio Plasma Protein Therapeutics Product Overview
Table 117. Hualan Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Hualan Bio Business Overview
Table 119. Hualan Bio Recent Developments
Table 120. Tiantan Bio Basic Information
Table 121. Tiantan Bio Plasma Protein Therapeutics Product Overview
Table 122. Tiantan Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Tiantan Bio Business Overview
Table 124. Tiantan Bio Recent Developments
Table 125. Shuanglin Bio Basic Information
Table 126. Shuanglin Bio Plasma Protein Therapeutics Product Overview
Table 127. Shuanglin Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shuanglin Bio Business Overview
Table 129. Shuanglin Bio Recent Developments
Table 130. Boya Bio Basic Information
Table 131. Boya Bio Plasma Protein Therapeutics Product Overview
Table 132. Boya Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Boya Bio Business Overview
Table 134. Boya Bio Recent Developments
Table 135. Yuanda Shuyang Basic Information
Table 136. Yuanda Shuyang Plasma Protein Therapeutics Product Overview
Table 137. Yuanda Shuyang Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Yuanda Shuyang Business Overview
Table 139. Yuanda Shuyang Recent Developments
Table 140. Weiguang Bio Basic Information
Table 141. Weiguang Bio Plasma Protein Therapeutics Product Overview
Table 142. Weiguang Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Weiguang Bio Business Overview
Table 144. Weiguang Bio Recent Developments
Table 145. Nanyue Bio Basic Information
Table 146. Nanyue Bio Plasma Protein Therapeutics Product Overview
Table 147. Nanyue Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Nanyue Bio Business Overview
Table 149. Nanyue Bio Recent Developments
Table 150. KM Biologics Basic Information
Table 151. KM Biologics Plasma Protein Therapeutics Product Overview
Table 152. KM Biologics Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. KM Biologics Business Overview
Table 154. KM Biologics Recent Developments
Table 155. Global Plasma Protein Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Plasma Protein Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Plasma Protein Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Plasma Protein Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Plasma Protein Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Plasma Protein Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Plasma Protein Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Plasma Protein Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Plasma Protein Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Plasma Protein Therapeutics Market Size by Type (M USD)
Table 4. Global Plasma Protein Therapeutics Market Size by Application
Table 5. Plasma Protein Therapeutics Market Size Comparison by Region (M USD)
Table 6. Global Plasma Protein Therapeutics Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Plasma Protein Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Plasma Protein Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2025)
Table 11. Global Market Plasma Protein Therapeutics Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Protein Therapeutics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Plasma Protein Therapeutics Sales by Type (K MT)
Table 27. Global Plasma Protein Therapeutics Market Size by Type (M USD)
Table 28. Global Plasma Protein Therapeutics Sales (K MT) by Type (2020-2025)
Table 29. Global Plasma Protein Therapeutics Sales Market Share by Type (2020-2025)
Table 30. Global Plasma Protein Therapeutics Market Size (M USD) by Type (2020-2025)
Table 31. Global Plasma Protein Therapeutics Market Share by Type (2020-2025)
Table 32. Global Plasma Protein Therapeutics Price (USD/KG) by Type (2020-2025)
Table 33. Global Plasma Protein Therapeutics Sales (K MT) by Application
Table 34. Global Plasma Protein Therapeutics Market Size by Application
Table 35. Global Plasma Protein Therapeutics Sales by Application (2020-2025) & (K MT)
Table 36. Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Table 37. Global Plasma Protein Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Plasma Protein Therapeutics Market Share by Application (2020-2025)
Table 39. Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
Table 40. Global Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 41. Global Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Table 42. Global Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Plasma Protein Therapeutics Market Size by Region (2020-2025)
Table 44. North America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 45. North America Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 47. Europe Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Plasma Protein Therapeutics Sales by Country (2020-2025) & (K MT)
Table 51. South America Plasma Protein Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Plasma Protein Therapeutics Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Plasma Protein Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Plasma Protein Therapeutics Production (K MT) by Region(2020-2025)
Table 55. Global Plasma Protein Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Plasma Protein Therapeutics Revenue Market Share by Region (2020-2025)
Table 57. Global Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Plasma Protein Therapeutics Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Takeda Basic Information
Table 63. Takeda Plasma Protein Therapeutics Product Overview
Table 64. Takeda Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Takeda Business Overview
Table 66. Takeda SWOT Analysis
Table 67. Takeda Recent Developments
Table 68. CSL Basic Information
Table 69. CSL Plasma Protein Therapeutics Product Overview
Table 70. CSL Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. CSL Business Overview
Table 72. CSL SWOT Analysis
Table 73. CSL Recent Developments
Table 74. Grifols Basic Information
Table 75. Grifols Plasma Protein Therapeutics Product Overview
Table 76. Grifols Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Grifols Business Overview
Table 78. Grifols SWOT Analysis
Table 79. Grifols Recent Developments
Table 80. Octapharma Basic Information
Table 81. Octapharma Plasma Protein Therapeutics Product Overview
Table 82. Octapharma Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Octapharma Business Overview
Table 84. Octapharma Recent Developments
Table 85. Kedrion Basic Information
Table 86. Kedrion Plasma Protein Therapeutics Product Overview
Table 87. Kedrion Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Kedrion Business Overview
Table 89. Kedrion Recent Developments
Table 90. LFB Group Basic Information
Table 91. LFB Group Plasma Protein Therapeutics Product Overview
Table 92. LFB Group Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. LFB Group Business Overview
Table 94. LFB Group Recent Developments
Table 95. Biotest Basic Information
Table 96. Biotest Plasma Protein Therapeutics Product Overview
Table 97. Biotest Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Biotest Business Overview
Table 99. Biotest Recent Developments
Table 100. BPL Basic Information
Table 101. BPL Plasma Protein Therapeutics Product Overview
Table 102. BPL Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BPL Business Overview
Table 104. BPL Recent Developments
Table 105. RAAS Basic Information
Table 106. RAAS Plasma Protein Therapeutics Product Overview
Table 107. RAAS Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. RAAS Business Overview
Table 109. RAAS Recent Developments
Table 110. CBPO Basic Information
Table 111. CBPO Plasma Protein Therapeutics Product Overview
Table 112. CBPO Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. CBPO Business Overview
Table 114. CBPO Recent Developments
Table 115. Hualan Bio Basic Information
Table 116. Hualan Bio Plasma Protein Therapeutics Product Overview
Table 117. Hualan Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Hualan Bio Business Overview
Table 119. Hualan Bio Recent Developments
Table 120. Tiantan Bio Basic Information
Table 121. Tiantan Bio Plasma Protein Therapeutics Product Overview
Table 122. Tiantan Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Tiantan Bio Business Overview
Table 124. Tiantan Bio Recent Developments
Table 125. Shuanglin Bio Basic Information
Table 126. Shuanglin Bio Plasma Protein Therapeutics Product Overview
Table 127. Shuanglin Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Shuanglin Bio Business Overview
Table 129. Shuanglin Bio Recent Developments
Table 130. Boya Bio Basic Information
Table 131. Boya Bio Plasma Protein Therapeutics Product Overview
Table 132. Boya Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Boya Bio Business Overview
Table 134. Boya Bio Recent Developments
Table 135. Yuanda Shuyang Basic Information
Table 136. Yuanda Shuyang Plasma Protein Therapeutics Product Overview
Table 137. Yuanda Shuyang Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Yuanda Shuyang Business Overview
Table 139. Yuanda Shuyang Recent Developments
Table 140. Weiguang Bio Basic Information
Table 141. Weiguang Bio Plasma Protein Therapeutics Product Overview
Table 142. Weiguang Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Weiguang Bio Business Overview
Table 144. Weiguang Bio Recent Developments
Table 145. Nanyue Bio Basic Information
Table 146. Nanyue Bio Plasma Protein Therapeutics Product Overview
Table 147. Nanyue Bio Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Nanyue Bio Business Overview
Table 149. Nanyue Bio Recent Developments
Table 150. KM Biologics Basic Information
Table 151. KM Biologics Plasma Protein Therapeutics Product Overview
Table 152. KM Biologics Plasma Protein Therapeutics Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. KM Biologics Business Overview
Table 154. KM Biologics Recent Developments
Table 155. Global Plasma Protein Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Plasma Protein Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Plasma Protein Therapeutics Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Plasma Protein Therapeutics Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Plasma Protein Therapeutics Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Plasma Protein Therapeutics Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Plasma Protein Therapeutics Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Plasma Protein Therapeutics Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Plasma Protein Therapeutics Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Plasma Protein Therapeutics Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Plasma Protein Therapeutics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Plasma Protein Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Protein Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Plasma Protein Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Plasma Protein Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Protein Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma Protein Therapeutics Product Life Cycle
Figure 13. Plasma Protein Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Plasma Protein Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Plasma Protein Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma Protein Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Plasma Protein Therapeutics
Figure 19. Global Plasma Protein Therapeutics Market PEST Analysis
Figure 20. Global Plasma Protein Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Plasma Protein Therapeutics Market Share by Type
Figure 27. Sales Market Share of Plasma Protein Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Plasma Protein Therapeutics by Type in 2025
Figure 29. Market Share of Plasma Protein Therapeutics by Type (2020-2025)
Figure 30. Market Share of Plasma Protein Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Plasma Protein Therapeutics Market Share by Application
Figure 33. Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Plasma Protein Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Plasma Protein Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Plasma Protein Therapeutics Market Share by Application in 2025
Figure 37. Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Plasma Protein Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Plasma Protein Therapeutics Market Size by Country in 2024
Figure 45. U.S. Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Plasma Protein Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Plasma Protein Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Plasma Protein Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Plasma Protein Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Plasma Protein Therapeutics Market Size by Country in 2024
Figure 55. Germany Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Plasma Protein Therapeutics Market Size by Region in 2024
Figure 68. China Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Plasma Protein Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Plasma Protein Therapeutics Market Size by Country in 2024
Figure 82. Brazil Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Plasma Protein Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Plasma Protein Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Plasma Protein Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Plasma Protein Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Plasma Protein Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Plasma Protein Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Plasma Protein Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Plasma Protein Therapeutics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Plasma Protein Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Protein Therapeutics Market Size (M USD), 2025-2035
Figure 5. Global Plasma Protein Therapeutics Market Size (M USD) (2020-2035)
Figure 6. Global Plasma Protein Therapeutics Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Protein Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma Protein Therapeutics Product Life Cycle
Figure 13. Plasma Protein Therapeutics Sales Share by Manufacturers in 2025
Figure 14. Global Plasma Protein Therapeutics Revenue Share by Manufacturers in 2025
Figure 15. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Plasma Protein Therapeutics Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma Protein Therapeutics Revenue in 2025
Figure 18. Industry Chain Map of Plasma Protein Therapeutics
Figure 19. Global Plasma Protein Therapeutics Market PEST Analysis
Figure 20. Global Plasma Protein Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Plasma Protein Therapeutics Market Share by Type
Figure 27. Sales Market Share of Plasma Protein Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Plasma Protein Therapeutics by Type in 2025
Figure 29. Market Share of Plasma Protein Therapeutics by Type (2020-2025)
Figure 30. Market Share of Plasma Protein Therapeutics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Plasma Protein Therapeutics Market Share by Application
Figure 33. Global Plasma Protein Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Plasma Protein Therapeutics Sales Market Share by Application in 2025
Figure 35. Global Plasma Protein Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Plasma Protein Therapeutics Market Share by Application in 2025
Figure 37. Global Plasma Protein Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Plasma Protein Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Plasma Protein Therapeutics Market Size by Region (2020-2025)
Figure 40. North America Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Plasma Protein Therapeutics Market Size by Country in 2024
Figure 45. U.S. Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Plasma Protein Therapeutics Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Plasma Protein Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Plasma Protein Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Plasma Protein Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Plasma Protein Therapeutics Market Size by Country in 2024
Figure 55. Germany Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Plasma Protein Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Plasma Protein Therapeutics Market Size by Region in 2024
Figure 68. China Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 79. South America Plasma Protein Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Plasma Protein Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Plasma Protein Therapeutics Market Size by Country in 2024
Figure 82. Brazil Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Plasma Protein Therapeutics Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Plasma Protein Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Plasma Protein Therapeutics Market Size by Region in 2024
Figure 92. Saudi Arabia Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Plasma Protein Therapeutics Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Plasma Protein Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Plasma Protein Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 106. China Plasma Protein Therapeutics Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Plasma Protein Therapeutics Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Plasma Protein Therapeutics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Plasma Protein Therapeutics Market Share Forecast by Type (2026-2035)
Figure 111. Global Plasma Protein Therapeutics Sales Forecast by Application (2026-2035)
Figure 112. Global Plasma Protein Therapeutics Market Share Forecast by Application (2026-2035)
More Publications
Global Pressure Monitoring Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
153 pages
Global Mri Magnet Shimming Coil Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
137 pages
Global Neurological Biomarkers Market Research Report 2026(Status and Outlook)
US$ 2,980.00
February 2026
153 pages
Global Plasma Fractionation Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
142 pages
Global Exoskeleton Robots Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
144 pages
